SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-230506
Filing Date
2006-11-09
Accepted
2006-11-09 16:47:43
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 466214
2 CONSULTING AGREEMENT dex1027.htm EX-10.27 17112
3 CERTIFICATION REQUIRED BY RULE 13A-14(A) OF HAROLD E. SELICK dex311.htm EX-31.1 8553
4 CERTIFICATION REQUIRED BY RULE 13A-14(A) OF CATHLEEN P. DAVIS dex312.htm EX-31.2 8567
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF HAROLD E. SELICK dex321.htm EX-32.1 3492
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF CATHLEEN P. DAVIS dex322.htm EX-32.2 3505
  Complete submission text file 0001193125-06-230506.txt   508848
Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 061202975
SIC: 2834 Pharmaceutical Preparations